Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 421, 461-462 (30 January 2003) | doi:10.1038/421461a
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Pharmacology Group Leader
- S*BIO Pte Ltd
- Singapore
Cardiovascular Electrophysiologist / Pharmacologist - GlaxoSmithKline
- GlaxoSmithKline
- Ware, Harlow - United Kingdom
Gates ploughs millions into plan for assault on killer diseases
Declan Butler
Microsoft founder Bill Gates is to provide US$200 million for basic biological research into the treatment and control of killer diseases such as malaria and tuberculosis.The initiative, a partnership between the Bill & Melinda Gates Foundation in Seattle, Washington, and the US National Institutes of Health (NIH), will establish several large consortia to research diseases that kill millions of people in poor countries, but which are often neglected by biomedical research programmes in rich countries.
To read this story in full you will need to login or make a payment (see right).
